Person

Caroline Dorsa

Director, Illumina, Inc.

Current S&P 500 boards
2
Current roles
2
Open-market buys
$152K
Open-market sales
$9.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • BIIB
    Biogen
    Director
    Jun 2016 – last filing Jun 2025

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 2, 2025BIIBBuy1,235$122.72$152K
Jun 10, 2021ILMNSale1,000$450.00$450K
Sep 22, 2016BIIBSale27,570$314.00$8.7M

SEC reporting-owner ID (CIK) 1181174 · all filings on EDGAR

Caroline Dorsa (ILMN, DUK) | USBoard